| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.10B | +16.5% |
| R&D Expense | $54.6M | +12.0% |
| SG&A Expense | $128.6M | +15.1% |
| Operating Income | $249.3M | +101.5% |
| Pre-tax Income | $171.8M | +861.9% |
| Income Tax | $59.7M | +1844.9% |
| Net Income | $112.1M | +686.1% |
| EPS (Basic) | $0.63 | +584.6% |
| EPS (Diluted) | $0.61 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.4M | -66.3% |
| Accounts Receivable | $177.0M | +21.9% |
| Current Assets | $308.4M | -16.9% |
| Total Assets | $5.79B | +26.4% |
| Current Liabilities | $218.1M | +49.7% |
| Long-term Debt | $1.48B | +19.1% |
| Total Liabilities | $1.91B | +27.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $309.7M | +82.4% |
| Investing Cash Flow | -$680.9M | -2397.1% |
| Financing Cash Flow | $243.4M | +1361.8% |
| +569.2% |
| Stockholders' Equity |
| $3.88B |
| +25.9% |